Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.015 | 0.6555 | 1 |
Loa Loa (eye worm) | amidase | 0.0026 | 0.0404 | 0.0404 |
Trypanosoma brucei | fatty-acid amide hydrolase, putative | 0.0026 | 0.0404 | 0.0616 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.015 | 0.6555 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 1 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.022 | 1 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0151 | 0.6582 | 0.6582 |
Mycobacterium ulcerans | peptide amidase, GatA | 0.0026 | 0.0404 | 0.0616 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0026 | 0.0404 | 0.0404 |
Echinococcus multilocularis | glutamyl tRNA(Gln) amidotransferase subunit A | 0.0026 | 0.0404 | 0.0404 |
Brugia malayi | putative amidase | 0.0026 | 0.0404 | 0.0404 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.022 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.6555 | 1 |
Plasmodium falciparum | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0026 | 0.0404 | 0.0616 |
Loa Loa (eye worm) | amidase | 0.0026 | 0.0404 | 0.0404 |
Mycobacterium tuberculosis | Possible amidase (aminohydrolase) | 0.0026 | 0.0404 | 0.0616 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.015 | 0.6555 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.015 | 0.6555 | 1 |
Mycobacterium tuberculosis | Probable amidase AmiC (aminohydrolase) | 0.0026 | 0.0404 | 0.0616 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.6555 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.022 | 1 | 1 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.022 | 1 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.015 | 0.6555 | 1 |
Brugia malayi | Amidase family protein | 0.0026 | 0.0404 | 0.0404 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.015 | 0.6555 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.015 | 0.6555 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.015 | 0.6555 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0018 | 0 | 0.5 |
Mycobacterium ulcerans | amidase | 0.0026 | 0.0404 | 0.0616 |
Mycobacterium ulcerans | lysophospholipase | 0.015 | 0.6555 | 1 |
Mycobacterium ulcerans | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0026 | 0.0404 | 0.0616 |
Mycobacterium tuberculosis | Probable amidase AmiA2 (aminohydrolase) | 0.0026 | 0.0404 | 0.0616 |
Mycobacterium ulcerans | amidase | 0.0026 | 0.0404 | 0.0616 |
Mycobacterium ulcerans | amidase | 0.0026 | 0.0404 | 0.0616 |
Trypanosoma cruzi | amidase, putative | 0.0026 | 0.0404 | 0.0616 |
Leishmania major | monoglyceride lipase, putative | 0.015 | 0.6555 | 1 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0151 | 0.6582 | 0.6582 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0026 | 0.0404 | 1 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0026 | 0.0404 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.015 | 0.6555 | 1 |
Plasmodium vivax | PST-A protein | 0.015 | 0.6555 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.6555 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0.0404 | 0.0616 |
Echinococcus granulosus | glutamyl tRNAGln amidotransferase subunit A | 0.0026 | 0.0404 | 0.0404 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.015 | 0.6555 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.015 | 0.6555 | 1 |
Mycobacterium ulcerans | amidase | 0.0026 | 0.0404 | 0.0616 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.015 | 0.6555 | 1 |
Plasmodium falciparum | esterase, putative | 0.015 | 0.6555 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.015 | 0.6555 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.015 | 0.6555 | 1 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0026 | 0.0404 | 1 |
Schistosoma mansoni | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0026 | 0.0404 | 0.0404 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0026 | 0.0404 | 0.0404 |
Mycobacterium tuberculosis | Probable amidase AmiD (acylamidase) (acylase) | 0.0026 | 0.0404 | 0.0616 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0026 | 0.0404 | 0.0404 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.6555 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.022 | 1 | 1 |
Trypanosoma cruzi | amidase, putative | 0.0026 | 0.0404 | 0.0616 |
Plasmodium vivax | glutamyl-tRNA(Gln) amidotransferase subunit A, putative | 0.0026 | 0.0404 | 0.0616 |
Mycobacterium tuberculosis | Probable amidase AmiB2 (aminohydrolase) | 0.0026 | 0.0404 | 0.0616 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.015 | 0.6555 | 1 |
Mycobacterium ulcerans | amidase | 0.0026 | 0.0404 | 0.0616 |
Brugia malayi | Amidase family protein | 0.0026 | 0.0404 | 0.0404 |
Schistosoma mansoni | amidase | 0.022 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 81.89 % | Analgesic activity in Swiss albino mouse assessed as inhibition of acetic acid-induced writhing at 0.029 mmol/kg. po dosed 1 hr before acetic acid challenge and measured during 30 mins post acetic acid challenge | ChEMBL. | 22818041 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.